FDA inspection
Synapse Biomedical Inc: FDA inspection ending Jan 18, 2023
FDA inspection 1195865 · No Action Indicated (NAI) · Oberlin, OH
Key facts
| Inspection ID | 1195865 |
|---|---|
| Firm | Synapse Biomedical Inc |
| FEI number | 3005868392 |
| Address | 300 Artino St |
| City | Oberlin |
| State | OH |
| ZIP | 44074 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Jan 18, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Postmarket Assurance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data